Effective Phaco Time and Endothelial Cell Loss When Using Veritas

Aloha Vision Consultants

Status: Enrolling

Conditions: Cataract

Treatments: Device: Veritas Vision System

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT07176416

CY-25-01

Details and patient eligibility

About

This study is a single center, prospective study of cumulative dissipated energy and endothelial cells loss per phacoemulsification procedure after successful cataract surgery. Subjects will be assessed 3 months postoperatively at a single visit. Clinical evaluations will include central corneal thickness, specular microscopy, as well as measurement of visual acuities at distance.

Enrollment: 50 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients undergoing age-related cataract surgery.
• Planned use of the Catalys Precision Laser System.
• Planned implantation of TECNIS intraocular lenses (IOLs).

Exclusion criteria

• Moderate-severe any disease state (deemed by the surgeon) that could increase risk of complicated cataract surgery (ie, pseudoexfoliation syndrome, zonular dehiscence, history of eye trauma, and prior refractive surgery).